- –World market, 2023
- –Projected, 2033
- –Growth a year (CAGR)
- 494Active clinical trials worldwide
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
US
China
Canada
Italy
Spain
Germany
France
UKAnti-Nerve Growth Factor by country and region
Australia
Brazil
Ecuador
Egypt
Hong Kong
India
Japan
Kenya
Malaysia
Mexico
New Zealand
Philippines
Russia
Saudi Arabia
Singapore
South Africa
Thailand
UAE"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 148 papers since 2021
- Pulsed radiofrequency neuromodulation of subchondral bone in knee osteoarthritis. Frontiers in pain research (Lausanne, Switzerland), 2026
- Functional peptide therapeutics for veterinary osteoarthritis: mechanisms, delivery systems, and translational priorities. Frontiers in veterinary science, 2026
- Fasinumab for osteoarthritis: a systematic review and meta-analysis of efficacy and safety. BMC musculoskeletal disorders, 2026
- Prospective, randomized, placebo-controlled, multicenter, double-blind, parallel-group, registration field trial evaluating izenivetmab, a caninized anti-nerve growth factor monoclonal antibody, administered quarterly to dogs with naturally occurring osteoarthritis. Veterinary and animal science, 2026
- Efficacy and safety of relfovetmab administered every three months for the treatment of pain associated with osteoarthritis in client-owned cats. Veterinary journal (London, England : 1997), 2026
Key companies in Anti-Nerve Growth Factor
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Teva Pharmaceutical Industries
Sanofi
Mitsubishi Tanabe Pharma Corporation
Merck KGaA
Astellas Pharma Inc.
Quick answers
How many clinical trials are running in Anti-Nerve Growth Factor?
ClinicalTrials.gov lists 494 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Anti-Nerve Growth Factor?
PubMed lists about 148 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.